Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Focus on Water Testing
4.2.2 Emerging Biosimilars Market
4.2.3 Increasing Demand for Packaged Food Products
4.3 Market Restraints
4.3.1 Dearth of Skilled Professionals
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Industry Type
5.1.1 Clinical Diagnostics
5.1.2 Microbiology
5.1.3 Pharmaceuticals
5.1.4 Biologics
5.1.5 Others
5.2 By Technology
5.2.1 Polymerase Chain Reaction
5.2.2 Immunoassays
5.2.3 Chromatography
5.2.4 Spectrometry
5.2.5 Other Technologies
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc.
6.1.2 FAPAS (A Division of Fera Science Limited)
6.1.3 LGC Limited
6.1.4 Merck KGaA
6.1.5 NSI Lab Solutions
6.1.6 QACS Ltd
6.1.7 Trilogy Analytical Laboratory
6.1.8 Waters Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS